MetaCap

XBiotech Earnings

NASDAQ: XBITHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.160.00 (0.00%)

At close: Oct 15, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 11, 2026

Fiscal period

Sep/2026

XBiotech earnings summary

XBiotech is scheduled to report Sep/2026 earnings on Nov 11, 2026. In its most recent report on Aug 13, 2026 (Q2 2026), XBIT posted EPS of $-0.22. Across the last 16 reports, XBIT shares moved an average of 8.5% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

XBIT earnings history

XBiotech reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 13, 2026—$-0.22—-0.9%
May 14, 2026—$-0.18—-1.2%
Mar 13, 2026—$-0.87—+3.5%
Nov 12, 2025—$-0.20—-13.6%
Aug 13, 2025—$-0.06—+1.6%
May 14, 2025—$-0.36—-6.6%
Mar 18, 2025—$-0.34—-9.9%
Nov 13, 2024—$-0.16—+2.6%
Aug 12, 2024—$-0.43—+8.4%
May 10, 2024—$-0.33—+1.4%
Mar 15, 2024—$-0.15—+26.9%
Nov 9, 2023—$-0.24—-3.4%
Aug 11, 2023—$-0.29—-1.8%
May 10, 2023—$-0.13—+47.8%
Mar 15, 2023—$-0.10—-2.6%
Nov 9, 2022—$-0.42—-3.1%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related